Literature DB >> 1962975

Sequence analysis of the leader RNA of two porcine coronaviruses: transmissible gastroenteritis virus and porcine respiratory coronavirus.

K W Page1, P Britton, M E Boursnell.   

Abstract

The leader RNA sequence was determined for two pig coronaviruses, transmissible gastroenteritis virus (TGEV), and porcine respiratory coronavirus (PRCV). Primer extension, of a synthetic oligonucleotide complementary to the 5' end of the nucleoprotein gene of TGEV was used to produce a single-stranded DNA copy of the leader RNA from the nucleoprotein mRNA species from TGEV and PRCV, the sequences of which were determined by Maxam and Gilbert cleavage. Northern blot analysis, using a synthetic oligonucleotide complementary to the leader RNA, showed that the leader RNA sequence was present on all of the subgenomic mRNA species. The porcine coronavirus leader RNA sequences were compared to each other and to published coronavirus leader RNA sequences. Sequence homologies and secondary structure similarities were identified that may play a role in the biological function of these RNA sequences.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1962975      PMCID: PMC7088910          DOI: 10.1007/bf00570024

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  29 in total

1.  Three intergenic regions of coronavirus mouse hepatitis virus strain A59 genome RNA contain a common nucleotide sequence that is homologous to the 3' end of the viral mRNA leader sequence.

Authors:  C J Budzilowicz; S P Wilczynski; S R Weiss
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

2.  Completion of the sequence of the genome of the coronavirus avian infectious bronchitis virus.

Authors:  M E Boursnell; T D Brown; I J Foulds; P F Green; F M Tomley; M M Binns
Journal:  J Gen Virol       Date:  1987-01       Impact factor: 3.891

3.  Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of free leader RNA in transcription.

Authors:  S Makino; S A Stohlman; M M Lai
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Antigenic differentiation between transmissible gastroenteritis virus of swine and a related porcine respiratory coronavirus.

Authors:  P Callebaut; I Correa; M Pensaert; G Jiménez; L Enjuanes
Journal:  J Gen Virol       Date:  1988-07       Impact factor: 3.891

5.  Presence of leader sequences in the mRNA of mouse hepatitis virus.

Authors:  M M Lai; C D Patton; R S Baric; S A Stohlman
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

6.  Enteric coronavirus TGEV: partial sequence of the genomic RNA, its organization and expression.

Authors:  D Rasschaert; J Gelfi; H Laude
Journal:  Biochimie       Date:  1987 Jun-Jul       Impact factor: 4.079

7.  Sequence analysis of nucleocapsid gene and leader RNA of human coronavirus OC43.

Authors:  T Kamahora; L H Soe; M M Lai
Journal:  Virus Res       Date:  1989-01       Impact factor: 3.303

8.  The integral membrane protein from a virulent isolate of transmissible gastroenteritis virus: molecular characterization, sequence and expression in Escherichia coli.

Authors:  P Britton; R S Cármenes; K W Page; D J Garwes
Journal:  Mol Microbiol       Date:  1988-07       Impact factor: 3.501

9.  Sequence analysis of the porcine transmissible gastroenteritis coronavirus nucleocapsid protein gene.

Authors:  P A Kapke; D A Brian
Journal:  Virology       Date:  1986-05       Impact factor: 3.616

10.  Sequence analysis of the nucleocapsid protein gene of human coronavirus 229E.

Authors:  S S Schreiber; T Kamahora; M M Lai
Journal:  Virology       Date:  1989-03       Impact factor: 3.616

View more
  8 in total

1.  Blocking eIF4E-eIF4G interaction as a strategy to impair coronavirus replication.

Authors:  Regina Cencic; Marc Desforges; David R Hall; Dima Kozakov; Yuhong Du; Jaeki Min; Raymond Dingledine; Haian Fu; Sandor Vajda; Pierre J Talbot; Jerry Pelletier
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

2.  Sequence comparison of porcine respiratory coronavirus isolates reveals heterogeneity in the S, 3, and 3-1 genes.

Authors:  E M Vaughn; P G Halbur; P S Paul
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

3.  Replication and packaging of transmissible gastroenteritis coronavirus-derived synthetic minigenomes.

Authors:  A Izeta; C Smerdou; S Alonso; Z Penzes; A Mendez; J Plana-Durán; L Enjuanes
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

4.  Genetic analysis of porcine respiratory coronavirus, an attenuated variant of transmissible gastroenteritis virus.

Authors:  R D Wesley; R D Woods; A K Cheung
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  Investigation of the control of coronavirus subgenomic mRNA transcription by using T7-generated negative-sense RNA transcripts.

Authors:  J A Hiscox; K L Mawditt; D Cavanagh; P Britton
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

6.  The cloning and sequencing of the virion protein genes from a British isolate of porcine respiratory coronavirus: comparison with transmissible gastroenteritis virus genes.

Authors:  P Britton; K L Mawditt; K W Page
Journal:  Virus Res       Date:  1991-11       Impact factor: 3.303

7.  Porcine Respiratory Coronavirus as a Model for Acute Respiratory Coronavirus Disease.

Authors:  Sarah Keep; Brigid Veronica Carr; Fabian Z X Lean; Albert Fones; Joseph Newman; Giulia Dowgier; Graham Freimanis; Eleni Vatzia; Noemi Polo; Holly Everest; Isobel Webb; Adam Mcnee; Basu Paudyal; Nazia Thakur; Alejandro Nunez; Ronan MacLoughlin; Helena Maier; John Hammond; Dalan Bailey; Ryan Waters; Bryan Charleston; Toby Tuthill; Paul Britton; Erica Bickerton; Elma Tchilian
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

8.  Quantification of individual subgenomic mRNA species during replication of the coronavirus transmissible gastroenteritis virus.

Authors:  J A Hiscox; D Cavanagh; P Britton
Journal:  Virus Res       Date:  1995-05       Impact factor: 3.303

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.